SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-000675
Filing Date
2024-01-05
Accepted
2024-01-05 07:00:30
Documents
15
Period of Report
2024-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240104_8k.htm   iXBRL 8-K 26796
2 EXHIBIT 99.1 ex_612114.htm EX-99.1 16757
7 ex_612114img001.jpg GRAPHIC 3748
  Complete submission text file 0001437749-24-000675.txt   186107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20240104.xsd EX-101.SCH 3400
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240104_def.xml EX-101.DEF 11420
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240104_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240104_pre.xml EX-101.PRE 11580
9 EXTRACTED XBRL INSTANCE DOCUMENT opk20240104_8k_htm.xml XML 2539
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 24514415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)